Literature DB >> 11159738

Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis.

D Qiao1, E D Stratagouleas, J D Martinez.   

Abstract

The bile acid deoxycholic acid (DCA) is a known tumor promoter and it has been suggested that DCA-induced apoptosis plays an important role in colon tumor development. In this study we have characterized the capacity of DCA to stimulate mitogen-activated protein kinase (MAPK) activity and examined the effect that MAPK activity had on DCA-induced apoptosis. Analysis of MAPK activity in DCA-treated HCT116 cells using phosphorylation-specific antibodies and in vitro kinase assays indicated that both the extracellular signal-regulated kinase (ERK) and p38 MAPK (p38), but not the c-Jun N-terminal kinase (JNK), were activated. Using pharmacological inhibitors we determined that only ERK could influence DCA cytotoxicity and that elevated ERK activity could suppress DCA-induced apoptosis. This observation was confirmed genetically. Suppressing ERK activity by overexpressing a dominant negative form of the ERK MAP kinase resulted in increased sensitivity to DCA-induced apoptosis whereas elevated ERK activity artificially produced by overexpression of the wild-type ERK kinase blunted DCA-induced apoptosis. Taken together, our results suggest that DCA can stimulate pro-apoptotic and anti-apoptotic signaling pathways and that sensitivity to DCA-induced apoptosis can be modulated by the ERK MAP kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159738     DOI: 10.1093/carcin/22.1.35

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  35 in total

1.  Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.

Authors:  Kunrong Cheng; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2006-12-10       Impact factor: 5.858

2.  Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.

Authors:  Jasleen Shant; Kunrong Cheng; Bernard S Marasa; Jian-Ying Wang; Jean-Pierre Raufman
Journal:  Exp Cell Res       Date:  2008-11-20       Impact factor: 3.905

3.  Synthesis, Structure-Activity Relationship, and Mechanistic Investigation of Lithocholic Acid Amphiphiles for Colon Cancer Therapy.

Authors:  Manish Singh; Sandhya Bansal; Somanath Kundu; Priyanshu Bhargava; Ashima Singh; Rajender K Motiani; Radhey Shyam; Vedagopuram Sreekanth; Sagar Sengupta; Avinash Bajaj
Journal:  Medchemcomm       Date:  2014-10-15       Impact factor: 3.597

Review 4.  Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.

Authors:  Sara M Centuori; Jesse D Martinez
Journal:  Dig Dis Sci       Date:  2014-06-11       Impact factor: 3.199

5.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

6.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

7.  Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR.

Authors:  Rebecca Feldman; Jesse D Martinez
Journal:  Biochim Biophys Acta       Date:  2009-05-13

8.  EphA2 up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence.

Authors:  Zhongyou Li; Masamitsu Tanaka; Hideki Kataoka; Ritsuko Nakamura; Ravshanov Sanjar; Kazuya Shinmura; Haruhiko Sugimura
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-15       Impact factor: 4.553

9.  Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells.

Authors:  Laxmi Yeruva; John Abiodun Elegbede; Stephen W Carper
Journal:  Anticancer Drugs       Date:  2008-09       Impact factor: 2.248

10.  Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Authors:  Eileen Looby; Mohamed M M Abdel-Latif; Veronica Athié-Morales; Shane Duggan; Aideen Long; Dermot Kelleher
Journal:  BMC Cancer       Date:  2009-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.